Avadel (AVDL) Probability Sentiment 2
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Probability Sentiment SUMMARY In March 2021, the FDA assigned an October [...]
Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update
Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and webcast at 8 am Eastern on July 13, 2020, to [...]
Avadel Shares Stable After Nice Run; Cassava Shares Languish on Alzheimer’s Blues
Avadel Pharmaceuticals plc (NASDAQ:AVDL) recently announced positive phase III trial results for its drug FT218 to treat excessive daytime sleepiness [...]
-
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020 GalleryAcceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Onconova Coverage suspended, Oragenics falls short in Phase II trial. The FDA last week approved Acceleron Pharma Inc. (NASDAQ:XLRN) luspatercept [...]